Thyrocare Technologies Ltd. News and Updates

Keep track of all breaking news on Thyrocare Technologies Ltd. from all sources in a single place.

Load latest

Thyrocare Technologies Ltd.

03 Aug 2018

973.00

-2.11%

Thyrocare Tech: Eyes on buyback meet

Business Line

The board of directors of Thyrocare Technologies will meet on Monday to consider a proposal to buy back equity shares. Investors and shareholders woul

Thyrocare Technologies Ltd. has gained 34.50% in the last 3 Months

Thyrocare Technologies Ltd.

30 Dec 2017

973.00

-2.11%

Thyrocare launches tuberculosis testing facility FocusTB

Business Line

Diagnostics services provider Thyrocare today announced the launch of FocusTB, its affordable brand focusing on TB diagnostics. With the launch of our TB offering, we hope to make a fundamental and...

Thyrocare Technologi.. has an average target of 1000.00 from 1 broker.

Thyrocare Technologies Ltd.

14 Dec 2017

973.00

-2.11%

Broker's Call

Business Line

JMFLThyrocare Tech (Buy)CMP: 657.45Target: 920In 2QFY18, Thyrocare's revenue/EBITDA/adjusted PAT grew 13 per cent/ 18 per cent/ 40 per cent y-o-y to 88 crore/ 35.7 crore/ 24.8 crore, respectively....

Thyrocare Technologi.. has an average target of 1000.00 from 1 broker.

Thyrocare Technologies Ltd.

06 Sep 2017

973.00

-2.11%

Thyrocare Technologies Ltd

Mgmt Note: Thyrocare Technologies Ltd.

ICICI Securities Limited

We met the management of Thyrocare Technologies (Thyrocare) to get an insight into the company's future plans as well as industry dynamics. The company operates mainly in diagnostics and nuclear imaging segments, which contribute 89% and 6% to total revenues, respectively. The diagnostic segment operates on a hub-and-spoke model and currently comprises one automated central processing lab (CPL) in Navi Mumbai and eight regional processing labs (RPL). The samples are aggregated and sent to CPL and RPL from 26 air connected hubs and...

Thyrocare Technologies Ltd. has gained 34.50% in the last 3 Months

Thyrocare Technologies Ltd.

28 Aug 2017

973.00

-2.11%

Norwest Venture sells 9.3% stake in Thyrocare for Rs335 crore

livemint

Norwest Venture Partners offloaded 9.3% stake in diagnostics chain Thyrocare Technologies for an estimated over Rs335 crore through open market transactions